- 全部删除
您的购物车当前为空
SIAIS178是一种靶向BCR-ABL的选择性PROTAC降解剂,IC50=24 nM,通过募集VHL E3 泛素连接酶来降解BCR-ABL蛋白,在体外抑制白血病细胞生长和导致K562异种移植肿瘤消退。


为众多的药物研发团队赋能,
让新药发现更简单!
SIAIS178是一种靶向BCR-ABL的选择性PROTAC降解剂,IC50=24 nM,通过募集VHL E3 泛素连接酶来降解BCR-ABL蛋白,在体外抑制白血病细胞生长和导致K562异种移植肿瘤消退。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,650 | In stock | |
| 5 mg | ¥ 3,980 | In stock | |
| 10 mg | ¥ 5,410 | In stock | |
| 25 mg | ¥ 8,460 | In stock | |
| 50 mg | ¥ 11,300 | In stock | |
| 100 mg | ¥ 15,300 | In stock | |
| 200 mg | ¥ 19,800 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 4,380 | In stock |
SIAIS178 相关产品
| 产品描述 | SIAIS178 is a selective PROTAC degrader targeting BCR-ABL with an IC50 of 24 nM. It degrades BCR-ABL protein by recruiting the VHL E3 ubiquitin ligase, inhibiting leukaemia cell growth in vitro and causing regression of K562 xenograft tumours. |
| 靶点活性 | VHL:24 nM, BCR-ABL:24 nM |
| 体外活性 | 方法:SIAIS178(1,3,10,30,100 nM,16小时)处理K562 细胞 |
| 体内活性 | 方法:SIAIS178(5,15,45mg/kg)处理K562-Luc的NOD / SCID小鼠,研究其对小鼠体内肿瘤的影响。 |
| 别名 | SIAI S178 |
| 分子量 | 1012.68 |
| 分子式 | C50H62ClN11O6S2 |
| CAS No. | 2376047-73-1 |
| Smiles | C([C@@H](NC(CCCCCCC(=O)N1CCN(CC1)C=2C=C(NC=3SC(C(NC4=C(C)C=CC=C4Cl)=O)=CN3)N=C(C)N2)=O)[C@](C)(C)C)(=O)N5[C@H](C(NCC6=CC=C(C=C6)C7=C(C)N=CS7)=O)C[C@@H](O)C5 |
| 密度 | 1.335 g/cm3 (Predicted) |
| 存储 | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 245 mg/mL (241.93 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容